MREC Reviewer Comment
Protocol Title
Targeted Nanovesicular Formulation of Meloxicam for Improved Neuropharmacological Outcomes in Depression Treatment
Completely satisfied and informative data
Needs Explanation
Comments to the applicant
please mention the safety precautions will be followed during blood and brain sampling
Comment to the Committee
Informed consent form:
N/A
